OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population

Arthritis Research and Therapy

Volumn 15, Issue 1, 2013, Pages

  Jiang, Yongqing ^a   Yao, Meng ^a   Liu, Qingpeng ^a   Zhou, Changwei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; THROMBIN;

AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIAL FLUID LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; WESTERN BLOTTING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOPONTIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SYNOVIAL FLUID;

EID: 84871742378     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4129     Document Type: Article

References (40)

1. Hunter DJ, Wilson DR. Imaging the role of biomechanics in osteoarthritis. Rheum Dis Clin North Am 2009, 35:465-483. 10.1016/j.rdc.2009.08.002, 19931799.
2. Coulibaly Y, Diakite AA, Keita M, Diakite I, Dembele M, Diallo G. Epidemiology and therapy of osteoarthritis in children. Mali Med 2009, 24:7-10.
3. Abramson SB. Inflammation in osteoarthritis. J Rheumatol Suppl 2004, 70:70-76.
4. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005, 44:7-16.
5. Benito MJ, Veale DJ, FitzGerald O, Van Den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005, 64:1263-1267. 10.1136/ard.2004.025270, 1755629, 15731292.
6. Esser S, Bailey A. Effects of exercise and physical activity on knee osteoarthritis. Curr Pain Headache Rep 2011, 15:423-430. 10.1007/s11916-011-0225-z, 21956792.
7. Bae JY, Park KS, Seon JK, Kwak DS, Jeon I, Song EK. Biomechanical analysis of the effects of medial meniscectomy on degenerative osteoarthritis. Med Biol Eng Comput 2012, 50:53-60. 10.1007/s11517-011-0840-1, 22038241.
8. Anderson DD, Marsh JL, Brown TD. The pathomechanical etiology of post-traumatic osteoarthritis following intraarticular fractures. Iowa Orthop J 2011, 31:1-20. 3215107, 22096414.
9. Zhang W, Doherty M. How important are genetic factors in osteoarthritis? Contributions from family studies. J Rheumatol 2005, 32:1139-1142.
10. Bian Q, Wang YJ, Liu SF, Li YP. Osteoarthritis: genetic factors, animal models, mechanisms, and therapies. Front Biosci (Elite Ed) 2012, 4:74-100.
11. Keen RW, Hart DJ, Lanchbury JS, Spector TD. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum 1997, 40:1444-1449. 10.1002/art.1780400812, 9259424.
12. Jin SY, Hong SJ, Yang HI, Park SD, Yoo MC, Lee HJ, Hong MS, Park HJ, Yoon SH, Kim BS, Yim SV, Park HK, Chung JH. Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population. Arthritis Res Ther 2004, 6:R415-421. 10.1186/ar1207, 546279, 15380041.
13. Magana JJ, Galvez-Rosas A, Gonzalez-Huerta C, Duarte-Salazar C, Lara-Alvarado L, Soria-Bastida MA, Cortes-Gonzalez S, Miranda-Duarte A. Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 2010, 17:157-160. 10.1016/j.knee.2009.08.006, 19736013.
14. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000, 19:615-622. 10.1016/S0945-053X(00)00108-6, 11102750.
15. Heilmann K, Hoffmann U, Witte E, Loddenkemper C, Sina C, Schreiber S, Hayford C, Holzlohner P, Wolk K, Tchatchou E, Moos V, Zeitz M, Sabat R, Günthert U, Wittig BM. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 2009, 13:1162-1174. 10.1111/j.1582-4934.2008.00428.x, 18627421.
16. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND, Nicholas SB. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009, 76:32-43. 10.1038/ki.2009.90, 19357716.
17. Zhivkova-Galunska M, Adwan H, Eyol E, Kleeff J, Kolb A, Bergmann F, Berger MR. Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines. Cancer Biol Ther 2010, 10:54-64. 10.4161/cbt.10.1.12161, 20495387.
18. Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 2009, 42:808-812. 10.1016/j.clinbiochem.2009.02.002, 19217889.
19. Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY, Kao SY. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol 2010, 46:302-306. 10.1016/j.oraloncology.2010.01.018, 20219412.
20. Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011, 2011:802581. 3205903, 22131818.
21. Mochida S, Hashimoto M, Matsui A, Naito M, Inao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fujiwara K. Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Biochem Biophys Res Commun 2004, 313:1079-1085. 10.1016/j.bbrc.2003.12.045, 14706653.
22. Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Eur J Immunol 2005, 35:1510-1520. 10.1002/eji.200425672, 15832294.
23. Kim Y, Lee C. Haplotype analysis revealed a genetic influence of osteopontin on large artery atherosclerosis. J Biomed Sci 2008, 15:529-533. 10.1007/s11373-008-9240-4, 18317949.
24. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049. 10.1002/art.1780290816, 3741515.
25. Hasegawa M, Nakoshi Y, Iino T, Sudo A, Segawa T, Maeda M, Yoshida T, Uchida A. Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis. J Rheumatol 2009, 36:240-245. 10.3899/jrheum.080753, 19208558.
26. Saitoh E, Matsui A, Inao M, Mimura S, Koh H, Ohno A, Nagoshi S, Kayano H, Yoshimoto T, Mochida S, Fujiwara K. Extrahepatic manifestations in transgenic mice of osteopontin in hepatocytes-A clue to advent of pathological state in various organs of chronic hepatitis C patients. Hepatol Res 2005, 31:197-202. 10.1016/j.hepres.2005.01.010, 15854888.
27. Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR. Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 2001, 44:578-584. 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.0.CO;2-7, 11263772.
28. Sharif SA, Du X, Myles T, Song JJ, Price E, Lee DM, Goodman SB, Nagashima M, Morser J, Robinson WH, Leung LL. Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum 2009, 60:2902-2912. 10.1002/art.24814, 19790060.
29. Hasegawa M, Segawa T, Maeda M, Yoshida T, Sudo A. Thrombin-cleaved osteopontin levels in synovial fluid correlate with disease severity of knee osteoarthritis. J Rheumatol 2011, 38:129-134. 10.3899/jrheum.100637, 21041276.
30. Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, Okazaki I, Seki N, Fujii T, Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003, 112:181-188. 164290, 12865407.
31. Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 2004, 20:87-96. 10.1152/physiolgenomics.00138.2004, 15479859.
32. Chiocchetti A, Indelicato M, Bensi T, Mesturini R, Giordano M, Sametti S, Castelli L, Bottarel F, Mazzarino MC, Garbarini L, Giacopelli F, Valesini G, Santoro C, Dianzani I, Ramenghi U, Dianzani U. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 2004, 103:1376-1382.
33. Chiocchetti A, Comi C, Indelicato M, Castelli L, Mesturini R, Bensi T, Mazzarino MC, Giordano M, D,Alfonso S, Momigliano-Richiardi P, Liguori M, Zorzon M, Amoroso A, Trojano M, Monaco F, Leone M, Magnani C, Dianzani U. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J Neuroimmunol 2005, 163:172-178. 10.1016/j.jneuroim.2005.02.020, 15885319.
34. Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007, 27:655-660. 10.1161/01.ATV.0000255560.49503.4e, 17170369.
35. Wang D, Yamamoto S, Hijiya N, Benveniste EN, Gladson CL. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 2000, 19:5801-5809. 10.1038/sj.onc.1203917, 11126367.
36. Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007, 57:373-380. 10.1016/j.lungcan.2007.04.005, 17513004.
37. Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Mol Carcinog 2009, 48:14-23. 10.1002/mc.20452, 18459127.
38. Zhao F, Chen X, Meng T, Hao B, Zhang Z, Zhang G. Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer. BMC Cancer 2012, 12:477. 10.1186/1471-2407-12-477, 3517443, 23072570.
39. Urcelay E, Martinez A, Mas-Fontao A, Peris-Pertusa A, Pascual-Salcedo D, Balsa A, Fernandez-Arquero M, de la Concha E. Osteopontin gene polymorphisms in Spanish patients with rheumatoid arthritis. J Rheumatol 2005, 32:405-409.
40. Xu G, Sun W, He D, Wang L, Zheng W, Nie H, Ni L, Zhang D, Li N, Zhang J. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol 2005, 32:410-416.